- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Alpelisib (BYL719)
Total 112 results
-
Celcuity, Inc.RecruitingBreast CancerKorea, Republic of, United States, Belgium, United Kingdom, Taiwan, France, Italy, Australia, Singapore, Argentina, Canada, India, Mexico, Czechia, Spain, Austria, Bulgaria, Germany, Hungary, Poland, Brazil, Greece, Romania
-
Dana-Farber Cancer InstituteNovartis; AstraZenecaCompleted
-
Memorial Sloan Kettering Cancer CenterNovartisCompleted
-
howard safranBrown University; Lifespan; Novartis Pharmaceuticals Corporation (Financial supporter)TerminatedRectal CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedHead and Neck Squamous Cell CancerUnited States
-
Julie E. Bauman, MD, MPHNovartisWithdrawnOropharyngeal Neoplasms | Oropharyngeal Cancer | Squamous Cell Carcinoma | Carcinoma, Squamous
-
AmgenCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedAdenocarcinoma Lung Cancer; Squamous Cell Lung CarcinomaChina
-
Korean Cancer Study GroupActive, not recruitingMetastatic Colorectal Cancer | PIK3CA Gene MutationKorea, Republic of
-
Baylor College of MedicineRecruitingAcute Ischemic StrokeUnited States
-
Novartis PharmaceuticalsCompletedNeoplasms, Breast Neoplasms, Head and Neck NeoplasmsUnited States, Spain, France, Italy
-
Assistance Publique Hopitaux De MarseilleUnknown
-
MedSIRNovartisRecruiting
-
Northwestern UniversityNational Cancer Institute (NCI); NovartisCompletedBYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane TxHER2-positive Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
Seoul National University Bundang HospitalRecruitingStomach Cancer | Solid TumorKorea, Republic of
-
Novartis PharmaceuticalsRecruitingBreast CancerRussian Federation
-
Advanced Accelerator ApplicationsActive, not recruitingPheochromocytoma | Paraganglioma | Gastroenteropancreatic Neuroendocrine TumorsUnited States, Spain, France, Poland, United Kingdom
-
Novartis PharmaceuticalsCompletedEstrogen Receptor Positive Breast Cancer | Advanced Solid Tumors With an Alteration of the PIK3CA GeneUnited States, Netherlands, Spain, Germany, United Kingdom
-
M.D. Anderson Cancer CenterOnconova Therapeutics, Inc.TerminatedLeukemia | Anemia | Myelofibrosis | SplenomegalyUnited States
-
Novartis PharmaceuticalsRecruiting
-
Boston UniversityCompleted
-
Priyanka SharmaNovartis PharmaceuticalsCompletedBreast CancerUnited States
-
Novartis PharmaceuticalsRecruitingHormone Receptor Positive HER2 Negative Breast Cancer With a PIK3CA MutationSpain, Italy, Austria
-
Novartis PharmaceuticalsRecruiting
-
UNICANCERTerminated
-
Columbia UniversityUniversity of California, BerkeleyRecruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Novartis PharmaceuticalsCompletedBreast CancerFrance, Singapore, Italy, Korea, Republic of, Taiwan, United Kingdom, Spain, United States
-
UNICANCERNovartis; Breast Cancer Research FoundationRecruiting
-
National Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma
-
Menzies School of Health ResearchThe University of Queensland; Australasian Society for Infectious Diseases; Singapore... and other collaboratorsTerminatedMethicillin-Resistant Staphylococcus AureusAustralia, New Zealand, Israel, Singapore
-
UNC Lineberger Comprehensive Cancer CenterNovartis PharmaceuticalsCompletedMetastatic Breast CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited Kingdom, France, Australia, Korea, Republic of, Spain, Switzerland, Italy, United States
-
Seoul National University HospitalChungnam National University Hospital; Korean Cancer Study GroupCompletedHead and Neck Neoplasms | HNSCCKorea, Republic of
-
Novartis PharmaceuticalsCompletedEsophageal Squamous Cell CarcinomaTaiwan, Spain, Canada, Singapore, Hong Kong, Korea, Republic of, Belgium, United Kingdom, United States
-
GOG FoundationNovartisRecruitingEndometroid Endometrial CancerUnited States
-
Borstkanker Onderzoek GroepNovartis Pharma B.V.; BOOG Study CenterRecruitingNeoplasm, Breast | Congenital, Familial and Genetic DisordersNetherlands
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedMetastatic or Locally-advanced Unresectable Breast CancerUnited States
-
Medical University of ViennaCompleted
-
Columbia UniversityCompletedInsulin Resistance | Dyslipidemias | HyperinsulinemiaUnited States
-
Hoffmann-La RocheRecruitingBreast CancerCanada, Belgium, Korea, Republic of, United States, China, Taiwan, Mexico, Brazil, Argentina, Australia, Italy, Spain, Turkey, Thailand, United Kingdom, Poland, South Africa
-
Novartis PharmaceuticalsCompletedNeoplasms | Kidney Neoplasms | Breast Neoplasms | Pancreatic Neuroendocine Neoplasms (pNETs)France, Germany, United States, Netherlands, Italy, Spain, United Kingdom, Hong Kong, Hungary
-
Marina N SharifiNovartis; University of Wisconsin, MadisonRecruitingHormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Novartis PharmaceuticalsRecruitingBreast CancerUnited States
-
Stemline Therapeutics, Inc.RecruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Criterium, Inc.Novartis; Seagen Inc.RecruitingHER2-positive Metastatic Breast CancerUnited States
-
SanofiActive, not recruitingBreast CancerCzechia, Belgium, Spain, United States, France, Canada, Italy, Poland, Portugal, United Kingdom
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedPancreatic CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBreast Cancer | Metastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
Peter MacCallum Cancer Centre, AustraliaTerminated